ClipTalk

Travie McCoy - Billionaire (Piano Cover)

kenjo93 — 04.02.2012, 23:48

Autor: kenjo93

: 04.02.2012, 23:48

Synalloy Corp. (SYNL) - Its Metal Segment Remains

karmastock — 04.02.2012, 20:30

Autor: karmastock

: 04.02.2012, 20:30

http://crwetube.com/media/synalloy-.....tal-segment-remains-stron

Welcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera. On its fourth quarter fiscal 2011, Synalloy Corporation - symbol SYNL - posted sales of $40,241,000, a 7% increase year over year, while its Net earnings for 2011 increased 44% to $5,797,000 or $0.91 per share compared to 2010. On its Metals Segment, Sales increased 9% to $29,974,000 while operating income increased 35% to $1,948,000 in the fourth quarter of 2011 from the same period a year earlier. Synalloy Corporation is structured as a holding company, currently comprised of two major groups: Metals and Chemicals. Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I�m Shalika Jayasekera.

***********************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwenewswire.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Threshold Pharmaceuticals (THLD) Global Agreement

karmastock — 04.02.2012, 20:06

Autor: karmastock

: 04.02.2012, 20:06

http://crwetube.com/media/threshold.....-thld-global-agreement-wi

Welcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera. Threshold Pharmaceuticals Incorporated - symbol THLD - reported that a global agreement was signed with Merck KGaA, Darmstadt, Germany, to co-develop and commercialize TH-302, Threshold�s small molecule hypoxia-targeted drug. Threshold will receive an upfront payment of $25 million and could receive up to $35 million in additional development milestones during 2012. Threshold is also eligible to receive a $20 million milestone payment based on positive results from its randomized Phase 2 trial in pancreatic cancer. Total potential milestone payments are $525 million, comprised of $280 million in regulatory and development milestones and $245 million in sales-based milestones. Threshold Pharmaceuticals is a biotechnology company focused on the discovery and development of drugs targeting tumor hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of patients with some hematologic malignancies. Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I�m Shalika Jayasekera.

***********************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwenewswire.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Threshold Pharmaceuticals (THLD) Global Agreement

karmastock — 04.02.2012, 20:05

Autor: karmastock

: 04.02.2012, 20:05

Welcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera. Threshold Pharmaceuticals Incorporated - symbol THLD - reported that a global agreement was signed with Merck KGaA, Darmstadt, Germany, to co-develop and commercialize TH-302, Threshold�s small molecule hypoxia-targeted drug. Threshold will receive an upfront payment of $25 million and could receive up to $35 million in additional development milestones during 2012. Threshold is also eligible to receive a $20 million milestone payment based on positive results from its randomized Phase 2 trial in pancreatic cancer. Total potential milestone payments are $525 million, comprised of $280 million in regulatory and development milestones and $245 million in sales-based milestones. Threshold Pharmaceuticals is a biotechnology company focused on the discovery and development of drugs targeting tumor hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of patients with some hematologic malignancies. Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I�m Shalika Jayasekera.

***********************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwenewswire.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

(ITI, CVCO, LIME) CRWENewswire Stocks to Watch for

karmastock — 03.02.2012, 01:54

Autor: karmastock

: 03.02.2012, 01:54

Welcome to CRWENewswire, Stocks to Watch for Friday February 3rd, 2012. I am Lynn Lumpkin. Iteris Incorporated - symbol ITI - reported financial results for its third quarter fiscal 2012, posting net sales and contract revenues of $14.9 million, a 24% increase compared to the same period the prior year.

(STEM, GMCR, DSCO) CRWENewswire Stocks In Action

karmastock — 02.02.2012, 20:12

Autor: karmastock

: 02.02.2012, 20:12

Good Morning, It�s Thursday February 2nd, 2012, I�m Christina Collins with CRWENewswire Stocks In Action. StemCells Incorporated - symbol STEM - reported that the FDA has authorized the initiation of a Phase I/II clinical trial of the Company�s proprietary HuCNS-SC product candidate (purified human neural stem cells) in dry age-related macular degeneration.

http://crwetube.com/media/stem-gmcr.....newswire-stocks-in-action

Di�tenerh�hung im D�sseldorfer Landtag - Comedy

Broemmelkamp — 02.02.2012, 19:44

Autor: Broemmelkamp

: 02.02.2012, 19:44

http://youtu.be/EEdmKCNinG8

Di�tenerh�hung im D�sseldorfer Landtag - Comedy

Broemmelkamp — 02.02.2012, 19:43

Autor: Broemmelkamp

: 02.02.2012, 19:43

http://youtu.be/EEdmKCNinG8

(ORN, CACI, ATHX) CRWENewswire Stocks to Watch for

karmastock — 02.02.2012, 16:54

Autor: karmastock

: 02.02.2012, 16:54

Welcome to CRWENewswire, Stocks to Watch for Thursday February 2nd, 2012. I am Shalika Jayasekera. Orion Marine Group Incorporated - symbol ORN - reported a berth construction contract award of approximately $12 million for the Canaveral Port Authority in Florida.

http://crwetube.com/media/orn-caci-.....ecom-stocks-to-watch-for-

http://www.youtube.com/watch?v=KU_cc8kQi6g

karmastock — 01.02.2012, 20:16

Autor: karmastock

: 01.02.2012, 20:16

Good Morning, It�s Wednesday February 1st, 2012, I�m Christina Collins with CRWENewswire Stocks In Action. Athersys Incorporated - symbol ATHX - reported grant funding aggregating $3.6 million to further advance its MultiStem product programs and cell therapy platform.

http://www.crwetube.com/media/athx-.....newswire-stocks-in-action

MatStepStudios:Boys vs. Girls "The Race"

Mouseartists — 01.02.2012, 19:56

Autor: Mouseartists

: 01.02.2012, 19:56

(PRXL, SMTX, LCI) CRWENewswire Stocks In Action

karmastock — 31.01.2012, 21:54

Autor: karmastock

: 31.01.2012, 21:54

Good Morning, It�s Tuesday January 31st, 2012, I�m Christina Collins with CRWENewswire Stocks In Action. On its Second Quarter Fiscal 2012 Financial Results, PAREXEL International Corporation - symbol PRXL - posted consolidated service revenue of $333.2 million, a 9.5% increase year over year.

http://crwetube.com/media/prxl-smtx.....newswire-stocks-in-action

(OTIV, TNB, LLEN) CRWENewswire Stocks In Action

karmastock — 30.01.2012, 21:04

Autor: karmastock

: 30.01.2012, 21:04

Good Morning, It�s Monday January 30th, 2012, I�m Christina Collins with CRWENewswire Stocks In Action. On Track Innovations Limited - symbol OTIV - reported that it has been awarded a Contract to Supply Electronic Immigration Control System in Panama. The company expects to recognize revenues of approximately $6.9 million, with the potential for additional revenue in future years from follow-on contracts. ABB Limited will acquire Thomas & Betts Corporation - symbol TNB - for $72 per share in cash or approximately $3.9 billion, and lastly L & L Energy Incorporated - symbol LLEN - reported that it has entered an agreement acquiring 51% controlling interest of the Weishe coal mine in China. Thank you for joining me and have a great day! For CRWE Newswire, Stocks In Action, I�m Christina Collins.

*********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. crwenewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer (Read more at http://www.crwenewswire.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold crwenewswire.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

http://www.youtube.com/watch?v=9OLS_ti3-R0

karmastock — 28.01.2012, 22:57

Autor: karmastock

: 28.01.2012, 22:57

Micronetics (NOIZ) Contract Valued at $2.0M

karmastock — 28.01.2012, 19:56

Autor: karmastock

: 28.01.2012, 19:56